Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grants Notification Service

Monday, January 26, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

Eyes on Washington: Federal Health Care Grants Notification Service

 

Grant Opportunities for January 19, 2014 through January 23, 2014

 

Visit Holland & Knight online

  

New Federal Health Care Grant Opportunities Announced for:

·         Administration for Children and Families (ACF)

·         Centers for Disease Control and Prevention (CDC)

·         Health Resources and Services Administration (HRSA)

·         Office of the Assistant Secretary for Health (OASH)

·         US Army Medical Research Acquisition Activity (USAMRAA)

·         National Institutes of Health (NIH)

 

NON-NIH Funding Opportunity Announcements:

 

ACF: Tribal Court Improvement Program

Funding Opportunity Number: HHS-2015-ACF-ACYF-CS-0973

This Funding Opportunity Announcement (FOA) seeks to provide tribes and tribal consortia the opportunity to compete for grants to enable tribal courts to: (1) conduct assessments of how tribal courts handle child welfare proceedings and to make improvements to court processes; (2) implement improvements to provide for the safety, permanency and well-being of children, and increase and improve engagement of the entire family in court processes relating to child welfare, family preservation, family reunification and adoption; (3) ensure children's safety, permanence, and well-being needs are met in a timely and complete manner (through better collection and analysis of data); and (4) provide for training of judges, attorneys, and other legal personnel in child welfare cases. This funding opportunity was announced on January 20, 2015. The application deadline is April 20, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

CDC: Natural Experiments of the Impact of Population-targeted Health Policies to Prevent Diabetes and its Complications

Funding Opportunity Number: RFA-DP-15-001

This Funding Opportunity Announcement (FOA) contains two components. Component A funds rigorous natural experiments on the impact of population-targeted health policies and large scale interventions on risk and complications of diabetes, as well as reducing disparities in these risks and complications. Specific goals of the Component A research program are to: (1) test the health impact of naturally occurring health policies and interventions, including public health policies, clinical-community partnerships, and health system-wide strategies; and (2) improve the methods and research infrastructure for natural experiments in public health. Findings could be used to inform the prioritization of policies and interventions for policy-makers, health plan directors, and community leaders. Component B funds a Central Coordinating Center to provide organizational, logistic and communication support to enhance the efficiency, productivity, and impact of the Natural Experiments research centers that are funded as part of Component A. This funding opportunity was announced on January 22, 2015. A letter of intent is due by February 24, 2015. The application deadline is March 24, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

 

 

 

CDC: Enhancing HIV Prevention Communication and Mobilization Efforts through Strategic Partnerships

Funding Opportunity Number: CDC-RFA-PS15-1505

Through this Funding Opportunity Announcement (FOA), CDC seeks to partner with national organizations that have a demonstrated reach and influence in one or more of the following targeted populations; the African American/Black, Hispanics/Latino, Gay, Bisexual Men Who Have Sex with Men (MSM), and Transgender populations in order to assist in HIV/AIDS prevention efforts. This funding opportunity was announced on January 22, 2015. The application deadline is March 23, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

HRSA: Rural Health Value Program

Funding Opportunity Number: HRSA-15-072

The purpose of the Rural Health Value Program is to inform rural health care providers and stakeholders such as HHS, Congress, states, and for-profit and nonprofit entities that set policies impacting rural health care providers about the impacts of changes in the health care delivery system, and to provide technical assistance to rural providers in identifying potential new approaches to health care delivery in their communities. The Office of Rural Health Policy (ORHP) funds community health organizations to test innovative approaches to improving the delivery of care in their communities.  Projects focus on a wide range of activities, including direct health care delivery, formation of networks to gain economies of scale and shared knowledge, implementation of quality of improvement strategies, and expansion of health care service delivery via telehealth. Evaluation of these awards documents outcomes and leads to the development of evidence-based practices that may be replicated in other communities. These best practices are shared with the broader rural health community primarily via the Rural Community Health Gateway. ORHP also funds technical assistance providers to work with grantees to implement best practices in their projects.  There are numerous opportunities to learn from and highlight the innovations of these grantees, and to share information with the technical assistance providers who support them. This funding opportunity was announced on January 20, 2015. The application deadline is March 23, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

HRSA: Maternal and Child Health (MCH) Interdisciplinary Education in Pediatric Pulmonary Centers (PPCs)

Funding Opportunity Number: HRSA-15-074

This Funding Opportunity Announcement (FOA) solicits applications for the Maternal and Child Health (MCH) Interdisciplinary Education in Pediatric Pulmonary Centers (PPCs).  The purpose of the PPC program is to improve the health status of infants, children, and youth with chronic respiratory conditions.  PPCs achieve this objective by addressing four aims: (1) providing interdisciplinary leadership training at the graduate and post-graduate levels in five core disciplines of pediatric pulmonary medicine, nursing, social work, nutrition, and family leadership.  PPCs serve as models of excellence in interdisciplinary training, systems integration, and research related to chronic respiratory conditions in infants, children, and youth; (2) engaging with families as full partners to support family-centered practice, policies, and research; (3) impacting policies and practices at the regional and national levels, including working with state and local health agencies and providers through a public health/population-based approach.  PPCs provide a critical link in assuring that the next generation of health care providers contribute to MCHB's mission to assure access to care for children and youth with special health care needs through systems improvement; and (4) supporting diverse trainees and faculty, and cultural and linguistic competence approaches, to address health disparities related to chronic respiratory conditions. This funding opportunity was announced on January 20, 2015. The application deadline is March 23, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

HRSA: Service Area Competition - Additional Areas (SAC-AA)

Funding Opportunity Number: HRSA-15-141

This Funding Opportunity Announcement (FOA) solicits applications for health centers in Atlanta, GA; Wichita, KS; New Iberia, LA; Port Gibson, MS; Superior, MT; Erie, PA; Charleston, SC; Waco, TX; and Inchelium, WA under the Health Center Program. Health centers improve the health of the Nation's underserved communities and vulnerable populations by ensuring access to comprehensive, culturally competent, quality primary health care services. Health Center Program grants support a variety of community-based and patient-directed public and private nonprofit organizations that serve an increasing number of the Nation's underserved. Individually, each health center plays an important role in the goal of ensuring access to services, and combined, they have had a critical impact on the health care status of medically underserved and vulnerable populations throughout the United States and its territories. The Health Center Program targets the Nation's neediest populations and geographic areas by currently funding approximately 1,300 health centers that operate over 9,000 service delivery sites in every state, the District of Columbia, Puerto Rico, the Virgin Islands, and the Pacific Basin.  In 2013, more than 21 million patients, including medically underserved and uninsured patients, received comprehensive, culturally competent, quality primary health care services through the Health Center Program, including Community Health Center (CHC, section 330(e)), Migrant Health Center (MHC, section 330(g)), Health Care for the Homeless (HCH, section 330(h)), and/or Public Housing Primary Care (PHPC, section 330(i)). This funding opportunity was announced on January 20, 2015. The application deadline is March 25, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

HRSA: EMS for Children: Pediatric Emergency Care Applied Research Network

Funding Opportunity Number: HRSA-15-066

The purpose of this Funding Opportunity Announcement (FOA) is to invite cooperative agreement applications from experienced clinical investigators to participate in the EMSC Pediatric Emergency Care Applied Research Network (PECARN). The goal of this FOA is to develop an efficient research network that will conduct high quality research and publish evidence-based findings that will impact clinical practice and ensure standardized care in diverse health care settings that serve children, including urban, rural and tribal settings. PECARN works with diverse demographic populations across varied geographical regions to promote the health of children in all phases of care.  The research will contribute to the pediatric health care delivery knowledge base and the findings will be especially important in health care settings where pediatric expertise may be limited. The goal of this network is to conduct meaningful and rigorous multi-institutional research into the treatment and management of acute illnesses and injuries in children and youth across the continuum of emergency medical health care. This infrastructure helps to overcome present challenges in accessing enough pediatric patients to assess efficacy, effectiveness and quality of care from the relatively small number of pediatric emergency events. The impact of the PECARN will be improved pediatric emergency and pre-hospital care for children, improved systems of care, and decreased morbidity and mortality among children in the acute care setting. This funding opportunity was announced on January 20, 2015. The application deadline is March 25, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

OASH: Availability of Funds for Embryo Donation and/or Adoption Grant Projects

Funding Opportunity Number: PA-EAA-15-001

The increasing success of assisted reproductive technologies (ART) has enabled some infertile couples to create embryos through in-vitro fertilization (IVF) that are then cryopreserved (frozen) for future use. If a couple becomes pregnant without using all of the stored embryos, they may choose to donate the remaining embryos for use by other infertile couples. Embryo donation is a relatively new process in which individuals with extra frozen embryos agree to release the embryos for use by another woman who wishes to achieve pregnancy. The recipient can be either anonymous or known to the donor(s). This notice solicits applications for projects in two categories: (1) projects that increase public awareness of embryo donation and/or adoption; and (2) projects that offer services, including counseling, to couples that are currently involved, or soon may be involved, in the process of embryo donation and/or adoption. Applicants may also propose a project that addresses both the public awareness aspect of the program and the “services” aspect in a single grant. This funding opportunity was announced on January 21, 2015. A letter of intent is due by March 15, 2015. The application deadline is April 21, 2015. For more information, please visit OASH's Full Funding Opportunity Announcement.

 

OASH: Availability of Funds for Phase I Research on Research Integrity

Funding Opportunity Number: IR-ORI-15-001

The purpose of this Funding Opportunity Announcement (FOA) is to foster innovative approaches to empirical research on societal, organizational, group, and individual factors that affect, both positively and negatively, integrity in research. Integrity is defined as the use of honest and verifiable methods in proposing, performing, and evaluating research and reporting research results with particular attention to adherence to rules, regulations, guidelines, and commonly accepted professional codes or norms. This funding opportunity was announced on January 21, 2015. A letter of intent is due by March 15, 2015. The application deadline is April 20, 2015. For more information, please visit OASH's Full Funding Opportunity Announcement.

 

USAMRAA: Alcohol and Substance Abuse Consortium Award

Funding Opportunity Number: W81XWH-14-ASARP-CA

The Alcohol and Substance Abuse Consortium Award (ASARP) Consortium Award will support the establishment of a Consortium that includes collaborations of multiple organizations and individuals for the purpose of identifying promising compounds with the goal of translating basic science knowledge into enhanced clinical pharmacological treatment protocols for ASUD. The Consortium will ultimately consist of a single Management Core as well as basic research and clinical trial sites. The participants will be jointly responsible for prioritizing, proposing, conducting and analyzing proof-of-principle basic research and proof-of-principle human clinical trials and developing a roadmap to translate promising basic science knowledge into enhanced clinical pharmacological treatment protocols for ASUD, including a regulatory strategy for FDA compliance. This funding opportunity was announced on January 22, 2015. The application deadline is March 5, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

NIH Funding Opportunity Announcements:

 

NIH: Assay Validation For High Quality Markers For NCI-Supported Clinical Trials 

Funding Opportunity Number: PAR-15-095 and PAR-15-096

The purpose of these Funding Opportunity Announcements (FOA) is to improve the development and validation of molecular diagnostics for the treatment, control, or prevention of cancer. These FOAs include, but are not limited to, the validation of prognostic, predictive or response markers for treatment and markers for cancer control or prevention trials. Applicants should have an assay that works in human samples and whose importance is well justified for development into a clinical assay. The PAR-15-095  FOA supports analytical validation of assays for these markers that must be achieved within two years before an assay may undergo clinical validation. The PAR-15-096 FOA supports the clinical validation of established assays for up to three years using specimens from retrospective or prospective studies from NCI-supported or other clinical trials. In both the FOAs, clinical laboratory staff, technical and other needs must be an integral part of the application. Assays proposed for these FOAs may be used to validate existing assays for use in other cancer clinical trials, observational studies or populations. Projects proposed for these FOAs will require multi-disciplinary interaction and collaboration among scientific investigators, clinicians, statisticians and clinical laboratory scientists and staff. This funding opportunity was announced on January 21, 2015. The initial application deadline is March 21, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcements for PAR-15-095 and PAR-15-096.

 

NIH: Prevention Research in Mid-Life Adults 

Funding Opportunity Number: PA-15-097 and PA-15-098

These Funding Opportunity Announcements (FOAs) seek to stimulate research on mid-life adults (50 to 64 years of age) that can inform efforts to optimize health and wellness as individuals age, and prevent illness and disability in later years. The specific goals of these FOAs are to (1) identify the unique characteristics of mid-life adults that impact health and wellness and contribute to the prevention of disease and disability; (2) identify characteristics, influences, and indicators that are important for optimal health in mid-life adults; and (3) develop strategies that promote health and wellness and prevent illness in this population. This funding opportunity was announced on January 22, 2015. The initial application deadline for PA-15-097 is June 16, 2015. The initial application deadline for PA-15-098 is June 5, 2015. For more information, please visit NIH's Full Funding Opportunity Announcements for PA-15-097 and PA-15-098.

 

NIH: Reductions in Illicit Drug Use and Functional Outcomes

Funding Opportunity Number: PA-15-099

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for Phased Innovation projects to determine whether reductions in illicit drug use are associated with positive changes in health-related and other functional outcomes in individuals with substance use disorders (SUDs). Functional outcomes include, for example, reductions in morbidity, mortality, criminal justice involvement, overall healthcare expenditures. This FOA provides support for up to two years for research planning activities and feasibility studies, followed by possible transition to expanded research support. The transition to the expanded research support phase will be determined by NIH program evaluation of successful achievement of the milestones set for the research planning phase. The ultimate goal of this FOA is to provide evidence that will enable regulatory authorities to accept reductions in illicit drug use as a valid outcome measure in clinical trials of pharmacotherapies for the treatment of SUDs. This funding opportunity was announced on January 23, 2015. A letter of intent is due by February 27, 2015. The initial application deadline is June 16, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Population Dynamics Centers Research Infrastructure

Funding Opportunity Number: RFA-HD-15-009

The goal of this Funding Opportunity Announcement (FOA) is to advance the field of population dynamics research by increasing research impact, innovation, and productivity; develop junior scientists; and maximize the efficiency of research support. The primary objectives of this initiative are to: (1) increase the scientific impact, innovation, productivity of population dynamics research; (2) increase competitiveness for peer-reviewed external funding in population dynamics research; (3) support career development experiences for junior population dynamics scientists that will contribute to their research independence; and (4) maximize the efficiency of funding for population dynamics research by minimizing the financial and time burdens of providing administrative and other research support services associated with research projects. This funding opportunity was announced on January 23, 2015. A letter of intent is due by February 27, 2015. The application deadline is March 27, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Medical Rehabilitation Research Resource

Funding Opportunity Number: RFA-HD-15-010

This Funding Opportunity Announcement (FOA) invites grant applications from institutions/organizations that propose to build research infrastructure to promote external collaboration with the medical rehabilitation community. The aim of this FOA is to create a national network of research cores that provide access to collateral expertise in biomedical, behavioral, engineering, and/or psychosocial fields that is particularly relevant to medical rehabilitation research. NIH is particularly interested in supporting infrastructure programs in clinical trial design, engineering and the environment, individualized medical rehabilitation and dynamic reassessment, and applied behavioral supports for rehabilitation research and healthy outcomes. However, other areas of expertise may be proposed provided they offer unique research opportunities and have potential for promoting medical rehabilitation research and improving outcomes for people with disabilities. In response to this FOA, applicants should propose a program of research resources and collaborative opportunities in a specific research domain. This may be accomplished through a workshops, written material, and websites, consultations, collaborations, and pilot funding. In addition, the research core may support activities within the grantee institution related to technique development, adaptation, and validation. To accomplish the aims of the FOA, applicants may propose collaborations to other institutional sites, provided that they cover the appropriate administrative and logistical issues. This funding opportunity was announced on January 23, 2015. A letter of intent is due by February 25, 2015. The application deadline is March 25, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Metabolomics Core for the Undiagnosed Diseases Network

Funding Opportunity Number: RFA-RM-15-001

This Funding Opportunity Announcement (FOA) is to establish a Metabolomics Core to augment clinical and laboratory findings of the Undiagnosed Diseases Network (UDN) and to assist the Network in the diagnosis of patients with undiagnosed diseases. Responsive applications will describe a plan to provide comprehensive analytical methods, analyses, technologies, and metabolomics expertise to the UDN to aid in clinical diagnosis and investigate potential mechanisms underlying phenotypic changes in patients. Due to the rare, even unique, disorders of UDN patients, applications should describe the need to develop specialized, "boutique" assays and methods of measurement in analyses of both normal and abnormal compounds of the diseased metabolome. This funding opportunity was announced on January 21, 2015. A letter of intent is due by March 15, 2015. The application deadline is April 15, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.


Association Management Software Powered by YourMembership  ::  Legal